EBS
Emergent BioSolutions Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 77 | 0 | 32.10M | $268.98M | +5 | −5 |
| Q1 2026 | 79 | +5 | 31.51M | $261.75M | +9 | −4 |
| Q4 2025 | 74 | 0 | 30.66M | $378.98M | — | — |
| Q3 2025 | 18 | +2 | 16.19M | $142.77M | +2 | — |
| Q2 2025 | 13 | 0 | 14.86M | $94.78M | — | — |
| Q1 2025 | 10 | -1 | 7.86M | $38.21M | — | −1 |
| Q4 2024 | 11 | +1 | 7.58M | $72.46M | +1 | — |
| Q3 2024 | 9 | 0 | 6.09M | $50.89M | +1 | −1 |
| Q2 2024 | 9 | — | 4.41M | $30.11M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Millennium Management ✦ | 946.30K | — | $6.45M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | D. E. Shaw & Co. ✦ | 827.80K | — | $5.65M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (pasivo) | 556.18K | — | $3.79M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (pasivo) | 556.18K | — | $3.79M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Marshall Wace ✦ | 542.81K | — | $3.70M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Marshall Wace ✦ | 542.81K | — | $3.70M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 460.31K | — | $3.14M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 460.31K | — | $3.14M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 460.31K | — | $3.14M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Two Sigma Investments ✦ | 446.54K | — | $3.05M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 346.35K | — | $2.36M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Renaissance Technologies ✦ | 173.75K | — | $1.18M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Wellington Management ✦ | 113.99K | — | $777,439 | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Wellington Management ✦ | 113.99K | — | $777,439 | 0.0% | n/c | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 187 tenedores, 43.00M acciones, $335.12M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.